Skip to main content
Top
Published in: Pediatric Nephrology 7/2008

01-07-2008 | Original Article

A new approach to the diagnosis of children’s urolithiasis based on the Bonn Risk Index

Authors: Tadeusz Porowski, Walentyna Zoch-Zwierz, Jerzy Konstantynowicz, Katarzyna Taranta-Janusz

Published in: Pediatric Nephrology | Issue 7/2008

Login to get access

Abstract

Published data on the association between calcium oxalate (CaOx) crystallization and kidney stone disease in children are scarce. The aims of this study were to determine CaOx crystallization using the Bonn Risk Index (BRI) in children with urolithiasis in comparison to healthy controls, to evaluate the relationships between BRI and urinary parameters, such as pH, calciuria, oxaluria and citraturia, and to assess the association between BRI and the size of renal stones. We compared the BRI in 142 Caucasian children and adolescents (76 girls, 66 boys) aged 3–18 years with kidney stones and 210 healthy age- and sex-matched controls without urolithiasis. Urinary ionized calcium ([Ca2+]) was measured using a selective electrode, while the onset of spontaneous crystallization was determined using a photometer and titration with 40 mmol/L ammonium oxalate (Ox2−). The calculation of the BRI value was based on the Ca2+:Ox2− ratio. High-resolution renal ultrasonography was carried out to estimate the size of the renal stones. The BRI values were 15-fold higher in children with renal stones than in healthy children without stones. The same trend was shown by BRI/kg body weight (tenfold greater in children with renal stones than in healthy children without stones), BRI/per 1.73 m2 body surface (13-fold greater) and BRI/body mass index (23-fold greater). No association was observed between BRI and the diameter of stones. Children with kidney stones, both males and females, had an increased BRI compared with subjects without urolithiasis. High BRI suggests an association with lower urinary pH, hypercalciuria, hyperoxaluria or hypocitraturia, which are all risk factors of kidney stones. An increased BRI in children, although unrelated to renal stone size, reflects the risk of calcium oxalate crystallization and may indicate early metabolic disorders leading to urolithiasis.
Literature
2.
go back to reference Hoppe B, Leumann E, von Unruh G, Laube N, Hesse A (2003) Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria. Front Biosci 8:437–443CrossRef Hoppe B, Leumann E, von Unruh G, Laube N, Hesse A (2003) Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria. Front Biosci 8:437–443CrossRef
3.
go back to reference Trinchieri A, Ostini F, Nespoli R, Rovera F, Zanetti G (1999) A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol 162:27–30CrossRefPubMed Trinchieri A, Ostini F, Nespoli R, Rovera F, Zanetti G (1999) A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol 162:27–30CrossRefPubMed
4.
go back to reference Sutherland JW, Parks JH, Coe FL (1985) Recurrence after a single renal stone in a community practice. Miner Electrolyte Metab 11:267–269PubMed Sutherland JW, Parks JH, Coe FL (1985) Recurrence after a single renal stone in a community practice. Miner Electrolyte Metab 11:267–269PubMed
5.
6.
go back to reference Kraus SJ, Lebowitz RL, Royal SA (1999) Renal calculi in children: imaging features that lead to diagnoses: a pictorial essay. Pediatr Radiol 29:624–630CrossRefPubMed Kraus SJ, Lebowitz RL, Royal SA (1999) Renal calculi in children: imaging features that lead to diagnoses: a pictorial essay. Pediatr Radiol 29:624–630CrossRefPubMed
7.
8.
go back to reference Kavanagh JP, Laube N (2006) Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls? J Urol 175:766–770CrossRefPubMed Kavanagh JP, Laube N (2006) Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls? J Urol 175:766–770CrossRefPubMed
9.
go back to reference Werness PG, Brown CM, Smith LH, Finlayson B (1985) EQUIL 2: a basic computer program for the calculation of urinary saturation. J Urol 134:1242–1244CrossRefPubMed Werness PG, Brown CM, Smith LH, Finlayson B (1985) EQUIL 2: a basic computer program for the calculation of urinary saturation. J Urol 134:1242–1244CrossRefPubMed
10.
go back to reference DeFoor W, Asplin J, Jackson E, Jackson C, Reddy P, Sheldon C, Erhard M, Minevich E (2006) Urinary metabolic evaluations in normal and stone forming children. J Urol 176:1793–1796CrossRefPubMed DeFoor W, Asplin J, Jackson E, Jackson C, Reddy P, Sheldon C, Erhard M, Minevich E (2006) Urinary metabolic evaluations in normal and stone forming children. J Urol 176:1793–1796CrossRefPubMed
11.
go back to reference Laube N, Schneider A, Hesse A (2000) A new approach to calculate the risk of calcium oxalate crystallization from unprepared native urine. Urol Res 28:274–280CrossRefPubMed Laube N, Schneider A, Hesse A (2000) A new approach to calculate the risk of calcium oxalate crystallization from unprepared native urine. Urol Res 28:274–280CrossRefPubMed
12.
go back to reference Laube N, Hergarten S, Hesse A (2002) Comparison of a laser-probe and photometric determination of the urinary crystallization risk of calcium oxalate. Clin Chem Lab Med 40:595–599CrossRefPubMed Laube N, Hergarten S, Hesse A (2002) Comparison of a laser-probe and photometric determination of the urinary crystallization risk of calcium oxalate. Clin Chem Lab Med 40:595–599CrossRefPubMed
13.
go back to reference Laube N, Labedzke V, Hergarten S, Hesse A (2002) Determination of urinary calcium-oxalate formation risk with BONN-Risk-Index and EQUIL applied to a family. J Chem Inf Comput Sci 42:633–639CrossRefPubMed Laube N, Labedzke V, Hergarten S, Hesse A (2002) Determination of urinary calcium-oxalate formation risk with BONN-Risk-Index and EQUIL applied to a family. J Chem Inf Comput Sci 42:633–639CrossRefPubMed
14.
go back to reference Lewandowski S, Rodgers AL, Laube N, von Unruh G, Zimmermann D, Hesse A (2005) Oxalate and its handling in a low stone risk vs a stone-prone population group. World J Urol 6:1–4 Lewandowski S, Rodgers AL, Laube N, von Unruh G, Zimmermann D, Hesse A (2005) Oxalate and its handling in a low stone risk vs a stone-prone population group. World J Urol 6:1–4
15.
go back to reference Porowski T, Zoch-Zwierz W, Wasilewska A, Spotyk A, Konstantynowicz J (2007) Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children. Pediatr Nephrol 22:514–520CrossRefPubMedPubMedCentral Porowski T, Zoch-Zwierz W, Wasilewska A, Spotyk A, Konstantynowicz J (2007) Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children. Pediatr Nephrol 22:514–520CrossRefPubMedPubMedCentral
16.
go back to reference Kunachowicz H, Nadolna I, Przygoda B, Iwanow K (eds) (1998) Food composition tables. National Food and Nutrition Institute, Warsaw Kunachowicz H, Nadolna I, Przygoda B, Iwanow K (eds) (1998) Food composition tables. National Food and Nutrition Institute, Warsaw
17.
go back to reference VanDervoort K, Wiesen J, Frank R, Vento S, Crosby V, Chandra M, Trachtman H (2007) Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol 177:2300–2305CrossRefPubMed VanDervoort K, Wiesen J, Frank R, Vento S, Crosby V, Chandra M, Trachtman H (2007) Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol 177:2300–2305CrossRefPubMed
18.
go back to reference Pietrow PK, Pope JC 4th, Adams MC, Shyr Y, Brock JW 3rd (2002) Clinical outcome of pediatric stone disease. J Urol 167:670–673CrossRefPubMed Pietrow PK, Pope JC 4th, Adams MC, Shyr Y, Brock JW 3rd (2002) Clinical outcome of pediatric stone disease. J Urol 167:670–673CrossRefPubMed
20.
go back to reference Tefekli A, Esen T, Ziylan O, Erol B, Armagan A, Ander H, Akinci M (2003) Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference? Urol Int 70:273–277CrossRefPubMed Tefekli A, Esen T, Ziylan O, Erol B, Armagan A, Ander H, Akinci M (2003) Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference? Urol Int 70:273–277CrossRefPubMed
21.
go back to reference Erbagci A, Erbagci AB, Yilmaz M, Yagci F, Tarakcioglu M, Yurtseven C, Koyluoglu O, Sarica K (2003) Pediatric urolithiasis—evaluation of risk factors in 95 children. Scand J Urol Nephrol 37:129–133CrossRefPubMed Erbagci A, Erbagci AB, Yilmaz M, Yagci F, Tarakcioglu M, Yurtseven C, Koyluoglu O, Sarica K (2003) Pediatric urolithiasis—evaluation of risk factors in 95 children. Scand J Urol Nephrol 37:129–133CrossRefPubMed
22.
go back to reference Laube N, Hergarten S, Hoppe B, Schmidt M, Hesse A (2004) Determination of the calcium oxalate crystallization risk from urine samples: the Bonn Risk Index in comparison to other risk formulas. J Urol 172:355–359CrossRefPubMed Laube N, Hergarten S, Hoppe B, Schmidt M, Hesse A (2004) Determination of the calcium oxalate crystallization risk from urine samples: the Bonn Risk Index in comparison to other risk formulas. J Urol 172:355–359CrossRefPubMed
23.
go back to reference Teller WM, Burke EC, Rosevear JW, McKenzie BF (1962) Urinary excretion of acid mucopolysaccharides in normal children and patients with gargoylism. J Lab Clin Med 59:95–101PubMed Teller WM, Burke EC, Rosevear JW, McKenzie BF (1962) Urinary excretion of acid mucopolysaccharides in normal children and patients with gargoylism. J Lab Clin Med 59:95–101PubMed
24.
go back to reference Bergsland KJ, Kinder JM, Asplin JR, Coe BJ, Coe FL (2002) Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients. J Urol 167:2372–2376CrossRefPubMed Bergsland KJ, Kinder JM, Asplin JR, Coe BJ, Coe FL (2002) Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients. J Urol 167:2372–2376CrossRefPubMed
25.
go back to reference Ricchiuti V, Hartke DM, Yang LZ, Goldman HB, Elder JS, Resnick MI, Marengo SR (2002) Levels of urinary inter-alpha-trypsin inhibitor trimer as a function of age and sex-hormone status in males and females not forming stones. BJU Int 90:513–517CrossRefPubMed Ricchiuti V, Hartke DM, Yang LZ, Goldman HB, Elder JS, Resnick MI, Marengo SR (2002) Levels of urinary inter-alpha-trypsin inhibitor trimer as a function of age and sex-hormone status in males and females not forming stones. BJU Int 90:513–517CrossRefPubMed
26.
go back to reference Moe OW, Preisig PA (2006) Dual role of citrate in mammalian urine. Curr Opin Nephrol Hypertens 15:419–424CrossRefPubMed Moe OW, Preisig PA (2006) Dual role of citrate in mammalian urine. Curr Opin Nephrol Hypertens 15:419–424CrossRefPubMed
27.
go back to reference Halperin ML, Cheema Dhadli S, Kamel KS (2006) Physiology of acid-base balance: Links with kidney stone prevention. Semin Nephrol 26:441–446CrossRefPubMed Halperin ML, Cheema Dhadli S, Kamel KS (2006) Physiology of acid-base balance: Links with kidney stone prevention. Semin Nephrol 26:441–446CrossRefPubMed
Metadata
Title
A new approach to the diagnosis of children’s urolithiasis based on the Bonn Risk Index
Authors
Tadeusz Porowski
Walentyna Zoch-Zwierz
Jerzy Konstantynowicz
Katarzyna Taranta-Janusz
Publication date
01-07-2008
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 7/2008
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-008-0786-1

Other articles of this Issue 7/2008

Pediatric Nephrology 7/2008 Go to the issue